In-Ho Chae
Seoul National University Bundang Hospital · Division of Cardiology, Department of Internal Medicine and Cardiovascular Center, Seoul National University Bundang Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name In-Ho Chae as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:05 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07796217 · Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban TherapySeoul National University Bundang Hospital · recruiting · Cardiac Event, Coronary Artery Disease, Peripheral Artery Disease · principal investigator
- Ph4NCT03847506 · Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination TabletsHK inno.N Corporation · completed · Hypertension, Hyperlipidemia · principal investigator
- Ph4NCT02299011 · Comparison of Biomatrix and Orsiro Drug Eluting StentSeoul National University Bundang Hospital · completed · Coronary Artery Disease, Myocardial Ischemia · principal investigator
- Ph4NCT01826552 · Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity StentSeoul National University Bundang Hospital · completed · Coronary Artery Disease, Coronary Heart Disease, Stable Angina · study director
- Ph2NCT01539603 · Comparison of Drug Eluting Balloon and Drug Eluting StentSeoul National University Bundang Hospital · completed · Coronary Artery Disease, Stable Angina, Unstable Angina · principal investigator
- Ph4NCT00776828 · The Efficacy of CILostazol ON Ischemic Complications After DES ImplantationSeoul National University Hospital · completed · Coronary Artery Disease · study chair
- Ph3NCT00699543 · The Efficacies of The New Paclitaxel-Eluting CoroflexTM Please Stent in Percutaneous Coronary InterventionSeoul National University Hospital · unknown · Coronary Artery Disease · study chair
- Ph4NCT00698607 · Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTingSeoul National University Hospital · completed · Coronary Artery Disease · study chair
- Ph4NCT00325936 · The Effects of Cilnidipine on Metabolic Syndrome ImprovementBoryung Pharmaceutical Co., Ltd · completed · Hypertension, Metabolic Syndrome X · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:05 UTC. The ranking covers the 200 most relevant of 85 PubMed records, and a shared surname and initials can bring in a namesake. All 85 on PubMed
- 519 citationsRCR 13.7
- Randomized trial of stents versus bypass surgery for left main coronary artery disease.N Engl J Med · 2011510 citationsRCR 14.0
- Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.J Am Coll Cardiol · 2015281 citationsRCR 8.9
- 260 citationsRCR 41.8
- Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.J Am Coll Cardiol · 2006223 citationsRCR 5.1
- 168 citationsRCR 4.6
- Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.Circulation · 2020149 citationsRCR 6.9
- 142 citationsRCR 4.3
- 116 citationsRCR 2.9
- 66 citationsRCR 1.9